Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-015834

Clovis Oncology, Inc. · CLVS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Feb 27, 2017
Accepted (ET)
Mar 1, 2017 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001466301

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Feb 27, 2017J1,139,890$0.00D0ISee Note 2
Common StockF4Feb 27, 2017J11,399$0.00A11,399ISee Note 4
Common StockF4Feb 27, 2017J11,399$0.00D0ISee Note 4
Common StockFeb 27, 2017J287$0.00A861D
Common StockF8Feb 27, 2017J287$0.00A861ISee Note 8

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses